IMP-4 and OXA β-lactamases in Acinetobacter baumannii from Singapore
Open Access
- 6 February 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 59 (4) , 627-632
- https://doi.org/10.1093/jac/dkl544
Abstract
To compare the incidence of carbapenemase genes in Acinetobacter baumannii between two time periods. We studied 114 isolates of imipenem-resistant A. baumannii collected over two 5 month periods (in 1996 and 2001). Isolates showing carbapenemase activity by plate bioassay were screened for carbapenemase genes using PCR. Chromosomal DNA from strains carrying carbapenemase genes was subjected to PFGE after digestion with ApaI. The incidence of imipenem-resistant A. baumannii in our hospital rose from 1.1 per 1000 admissions in 1996 to 2.3 per 1000 admissions in 2001. However, the number of carbapenemase-producing A. baumannii rose only slightly in 2001 (0.8 per 1000 admissions) compared to 1996 (0.5 per 1000 admissions). Of 44 isolates with carbapenemase activity, 4 isolates carried blaIMP-4, 5 carried blaOXA-58, and 40 carried blaOXA-23. In addition, most isolates carried a blaOXA-51-type β-lactamase gene. All strains with blaIMP-4, also carried blaOXA-58 and blaPSE-1, but not blaOXA-51-type β-lactamase genes. PCR analysis repeated on seven recent isolates of susceptible A. baumannii showed only the presence of blaOXA-51-type β-lactamase genes. A total of five novel blaOXA-51-type β-lactamase genes (blaOXA-88,-91,-93,-94, and -95) and one new blaOXA-58-type β-lactamase gene (blaOXA-96) were found. The incidence of carbapenemase genes did not vary significantly between the two study periods. There is a wide diversity of OXA genes in A. baumannii in Singapore. The most common carbapenemase gene found in our study was blaOXA-23.Keywords
This publication has 29 references indexed in Scilit:
- Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiologyClinical Microbiology & Infection, 2006
- OXA β-lactamases in Acinetobacter: the story so farJournal of Antimicrobial Chemotherapy, 2005
- Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2005
- The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continentsClinical Microbiology & Infection, 2005
- A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58Journal of Antimicrobial Chemotherapy, 2005
- OXA-58, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems inAcinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2005
- VIM- and IMP-Type Metallo-ß-lactamase–ProducingPseudomonasspp. andAcinetobacterspp. in Korean HospitalsEmerging Infectious Diseases, 2003
- Metallo-β-Lactamases in Clinical Pseudomonas Isolates in Taiwan and Identification of VIM-3, a Novel Variant of the VIM-2 EnzymeAntimicrobial Agents and Chemotherapy, 2001
- IMP-4, a Novel Metallo-β-Lactamase from Nosocomial Acinetobacter spp. Collected in Hong Kong between 1994 and 1998Antimicrobial Agents and Chemotherapy, 2001
- Characterization of OXA-25, OXA-26, and OXA-27, Molecular Class D β-Lactamases Associated with Carbapenem Resistance in Clinical Isolates of Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2001